Somatotropic adenomas without acromegaly
- PMID: 1792190
- DOI: 10.1016/s0344-0338(11)81065-4
Somatotropic adenomas without acromegaly
Abstract
Seventeen somatotropic adenomas removed from patients without acromegaly were studied. Thirteen of them presented as a prolactinoma with amenorrhea and/or galactorrhea and elevated serum PRL levels. According to basal serum GH levels, the patients were divided into two groups, namely Group I: GH slightly elevated (n = 4) and group II: GH less than or equal to 5 micrograms/l (n = 13). The tumoral GH secretion was proved by immunocytochemistry in all cases and by intratumoral RIA, in vitro study and/or in situ hybridization in five of them. Pathological, clinical and biochemical relationships suggested two anatomoclinical aspects. In group I, the tumors were small, well-differentiated somatotropic adenomas with clinically silent GH hypersecretion. It is probably an early stage of the disease. In group II, the tumors were large with normal GH serum levels. They were poorly differentiated and secreted very low amounts of GH. In nine of them, PRL and/or PRL mRNA expression were also detected. These tumors do not secrete enough GH to increase serum levels and cause acromegaly. The somatotropic adenomas without acromegaly correspond to two anatomoclinical aspects of the disease.
Similar articles
-
Differences Between GH- and PRL-Cosecreting and GH-Secreting Pituitary Adenomas: a Series of 604 Cases.J Clin Endocrinol Metab. 2024 Nov 18;109(12):e2178-e2187. doi: 10.1210/clinem/dgae126. J Clin Endocrinol Metab. 2024. PMID: 38436926
-
Detection of growth hormone, prolactin and human beta-chorionic gonadotropin mRNA in growth hormone-secreting pituitary adenomas and in prolactin-secreting pituitary adenomas by in situ hybridization using a non-isotopic detection method.Acta Endocrinol (Copenh). 1993 May;128(5):411-7. doi: 10.1530/acta.0.1280411. Acta Endocrinol (Copenh). 1993. PMID: 8317187
-
Apparently silent somatotroph adenomas.Pathol Res Pract. 1991 Dec;187(8):950-6. doi: 10.1016/S0344-0338(11)81066-6. Pathol Res Pract. 1991. PMID: 1792191
-
Diagnosis and treatment of pituitary adenomas.Minerva Endocrinol. 2004 Dec;29(4):241-75. Minerva Endocrinol. 2004. PMID: 15765032 Review.
-
Current diagnosis of acromegaly.Rev Endocr Metab Disord. 2008 Mar;9(1):13-9. doi: 10.1007/s11154-007-9060-2. Rev Endocr Metab Disord. 2008. PMID: 18236162 Review.
Cited by
-
Clinical profile of silent growth hormone pituitary adenomas; higher recurrence rate compared to silent gonadotroph pituitary tumors, a large single center experience.Endocrine. 2017 Dec;58(3):528-534. doi: 10.1007/s12020-017-1447-6. Epub 2017 Oct 17. Endocrine. 2017. PMID: 29043561
-
Absence of immunostaining for growth hormone in a subset of patients with acromegaly.Pituitary. 2014 Apr;17(2):103-8. doi: 10.1007/s11102-013-0474-4. Pituitary. 2014. PMID: 23475513
-
Pituitary adenomas that show a faint GH-immunoreactivity but lack fibrous body: Pit-1 adenoma with endocrinologically low activity.Endocr Pathol. 2010 Mar;21(1):40-7. doi: 10.1007/s12022-009-9105-z. Endocr Pathol. 2010. PMID: 20111911
-
Silent somatotroph pituitary adenomas: an update.Pituitary. 2018 Apr;21(2):194-202. doi: 10.1007/s11102-017-0858-y. Pituitary. 2018. PMID: 29305680 Review.
-
Modification of hormonal secretion in clinically silent pituitary adenomas.Pituitary. 2009;12(1):80-6. doi: 10.1007/s11102-008-0085-7. Pituitary. 2009. PMID: 18350381 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical